ATS 2020 Advance Program

12:35 A Novel Home-Based Pulmonary Rehabilitation Program K. Artis, MD, MPH, Portland, OR 12:55 Role of a Technology-Mediated Physical Activity Intervention in Pulmonary Rehabilitation M. Moy, MD, MSc, Boston, MA NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES L12 PULMONARY HEALTH IMPACTS OF E-CIGARETTES AND VAPING: WHAT’S EMERGING? 12:15 p.m. - 1:15 p.m. Target Audience Clinicians, clinician scientists, basic research scientists, fellows and residents. Objectives At the conclusion of this session, the participant will be able to: • gain understanding of the current state of science on the impacts of e-cigarettes and vaping and emerging biomarkers; • gain knowledge on the diverse numbers of flavoring agents, toxic metal constituents in the vape; • understand pulmonary and extrapulmonary impacts of e-cigarettes in utero exposure on adult offspring. The use of such as electronic cigarettes (e-cigarettes) is gaining popularity all over the world partially due to the addition of multiple flavoring agents. E-cigarettes are widely marketed as safer alternatives to traditional cigarettes because of reduced levels of nicotine delivered by inhalation. The safety claims of e-cigarette usage, however, are not supported by rigorous unbiased evaluation of potential health effects. Research findings from different laboratories suggest that e-cigarette aerosols components may be as harmful as the aerosols from combustion of cigarettes. This session will highlight recent research findings on the adverse health impacts on cardiopulmonary function, lung injury as well as neurodevelopmental effects associated with exposure to e-cigarette aerosol components. Chairing: S.S. Nadadur, PhD, Research Triangle Park, NC I. Rahman, PhD, ATSF, Rochester, NY 12:15 Introduction F. Tyson, PhD, Durham, NC 12:21 E-Cigarettes and Flavoring Chemicals-Induced Lung Cellular Effects and Their Potential Biomarkers I. Rahman, PhD, ATSF, Rochester, NY 12:39 Electronic Cigarettes Disrupt Lung Lipid Homeostasis and Innate Immunity F. Kheradmand, MD, Houston, TX 12:57 Health Impacts of Vaping During Pregnancy on Neonates and Adult Offspring Mice J. Zelikoff, PhD, Tuxedo, NY NATIONAL CENTER FOR ENVIRONMENTAL HEALTH/CDC L13 PREVENTING HOSPITALIZATIONS AND ED VISITS IN CHILDREN WITH ASTHMA 12:15 p.m. - 1:15 p.m. Target Audience Providers serving children with asthma; those who work with public health, communities and natural disasters. Objectives At the conclusion of this session, the participant will be able to: • learn the national surveillance data for children with asthma; • understand how multisector partnerships can help to reduce asthma burden; • understand the role of public health in helping children with asthma after a disaster. Addressing asthma control is imperative for reducing the large, unequally-distributed burden of disease. Reducing ATS 2020 • Philadelphia, PA MONDAY • MAY 18 79